A small proportion of tumors (6%, 39 of 623) demonstrated positivity for mammaglobin and negativity for GATA3; the majority of them were categorized as invasive breast carcinomas of no special type (82%, 32 of 39). This evidence concerns the gene GATA3 and invasive breast carcinoma.